Developing new methods to create complex natural products for treating cancer and inflammation
Renewal: Strategies and Methods for Complex Molecule Synthesis
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA BERKELEY · NIH-11004039
This study is all about finding new ways to create natural compounds that can help treat cancer, inflammation, and pain, so we can develop better medicines for people who need them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA BERKELEY (nih funded) |
| Locations | 1 site (BERKELEY, UNITED STATES) |
| Trial ID | NIH-11004039 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative strategies for synthesizing biologically active natural products, which are complex molecules that can have therapeutic effects. The team aims to efficiently prepare these compounds to develop new small molecules that can combat cancer, inflammation, and pain. By utilizing advanced organic synthesis techniques, they will explore new applications for modifying these molecules to enhance their effectiveness. Collaborations will also allow for the exploration of how these natural products can influence biological functions, potentially leading to new therapeutic options.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals suffering from cancer or inflammatory conditions who may benefit from novel therapeutic approaches.
Not a fit: Patients with conditions unrelated to cancer or inflammation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for cancer and inflammatory diseases.
How similar studies have performed: Previous research has shown promise in developing new therapies from natural products, indicating a potential for success in this approach.
Where this research is happening
BERKELEY, UNITED STATES
- UNIVERSITY OF CALIFORNIA BERKELEY — BERKELEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SARPONG, RICHMOND — UNIVERSITY OF CALIFORNIA BERKELEY
- Study coordinator: SARPONG, RICHMOND
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Disease, Disorder